Literature DB >> 4842036

Remarks on radioisotope studies of the leptomeningeal and ependymal spaces.

R Oberson, A Kushelevsky.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4842036     DOI: 10.1007/bf00344319

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


× No keyword cloud information.
  12 in total

Review 1.  The radionuclide imaging process and factors influencing the choice of an instrument for brain scanning.

Authors:  J Mallard
Journal:  Prog Nucl Med       Date:  1972

2.  Radioisotope ventriculography.

Authors:  R Oberson; R Campiche
Journal:  Neuroradiology       Date:  1973-08       Impact factor: 2.804

3.  Adverse reactions following 3In-DTPA cisternography.

Authors:  P O Alderson; B A Siegel
Journal:  J Nucl Med       Date:  1973-08       Impact factor: 10.057

4.  Biological behavior of 169 Yb-DTPA after intrathecal administration.

Authors:  F H DeLand
Journal:  J Nucl Med       Date:  1973-02       Impact factor: 10.057

5.  Spinal cord dosimetry in 169Yb and 111In DTPA thecography.

Authors:  A Kushelevsky; R Oberson
Journal:  Radiol Clin Biol       Date:  1974

Review 6.  [Myeloscintigraphy (critical and comparative review of its results)].

Authors:  R Oberson
Journal:  J Radiol Electrol Med Nucl       Date:  1970-10

7.  Chelated 111 In: an ideal radiopharmaceutical for cisternography.

Authors:  F Hosain; P Som
Journal:  Br J Radiol       Date:  1972-09       Impact factor: 3.039

8.  [Scintigraphic pattern of the 3d circulation].

Authors:  R Oberson
Journal:  Schweiz Arch Neurol Neurochir Psychiatr       Date:  1971

9.  A new radiopharmaceutical for cisternography: chelated ytterbium 169.

Authors:  H N Wagner; F Hosain; F H DeLand; P Som
Journal:  Radiology       Date:  1970-04       Impact factor: 11.105

10.  Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom.

Authors:  W S Snyder; H L Fisher; M R Ford; G G Warner
Journal:  J Nucl Med       Date:  1969-08       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.